CompletedN/Aketamine
Observation of Safety and Tolerability Within 1 Year of the Use of R-ketamine / Placebo in Drug-resistant Depression
Sponsored by Medical University of Gdansk
NCT ID
NCT06232291
Target Enrollment
3 participants
Start Date
2023-04-21
Est. Completion
2024-05-24
About This Study
An observational-comparative study, without interfering with the treatment, based on an operationalized interview.
Conditions Studied
Eligibility
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria: Expressing informed consent to participate in the study and earlier participation in the PCN-101-21 study on site. Exclusion Criteria: Informed consent withdrawal.
Study Locations (1)
Medical University of Gdańsk
Gdansk, Poland